These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28263159)

  • 1. [Dyskinesia in Parkinson's disease: an update on new neuroimaging methods and treatment possibilities].
    Thomsen BL; Herz DM; Siebner HR; Løkkegaard A
    Ugeskr Laeger; 2017 Mar; 179(10):. PubMed ID: 28263159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia.
    Fan SY; Wang KL; Hu W; Eisinger RS; Han A; Han CL; Wang Q; Michitomo S; Zhang JG; Wang F; Ramirez-Zamora A; Meng FG
    Ann Clin Transl Neurol; 2020 Jan; 7(1):59-68. PubMed ID: 31813194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment.
    Zesiewicz TA; Sullivan KL; Hauser RA
    Curr Neurol Neurosci Rep; 2007 Jul; 7(4):302-10. PubMed ID: 17618536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of sigma-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study.
    Nimura T; Ando T; Yamaguchi K; Nakajima T; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2004 Apr; 100(4):606-10. PubMed ID: 15070112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment and future prospects of dopa-induced dyskinesias.
    Mazzucchi S; Frosini D; Bonuccelli U; Ceravolo R
    Drugs Today (Barc); 2015 May; 51(5):315-29. PubMed ID: 26097904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of Tianqi Pingchan Granule, a compound Chinese herbal medicine, for levodopa-induced dyskinesia in Parkinson's disease: A randomized double-blind placebo-controlled trial.
    Zhang Y; Zhu XB; Zhao Y; Cui GY; Li WT; Yuan CX; Huang JP; Wan Y; Wu N; Song L; Zhao JH; Liang Y; Xu CY; Liu MJ; Gao C; Chen XX; Liu ZG
    J Integr Med; 2024 Sep; 22(5):545-551. PubMed ID: 39060125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease.
    Kim JH; Chang WS; Jung HH; Chang JW
    Yonsei Med J; 2015 Sep; 56(5):1316-21. PubMed ID: 26256974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease.
    Guridi J; Obeso JA; Rodriguez-Oroz MC; Lozano AA; Manrique M
    Neurosurgery; 2008 Feb; 62(2):311-23; discussion 323-5. PubMed ID: 18382309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3).
    Oertel W; Eggert K; Pahwa R; Tanner CM; Hauser RA; Trenkwalder C; Ehret R; Azulay JP; Isaacson S; Felt L; Stempien MJ
    Mov Disord; 2017 Dec; 32(12):1701-1709. PubMed ID: 28833562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-Release Amantadine for Levodopa-Induced Dyskinesia.
    Dashtipour K; Tafreshi AR; Pahwa R; Lyons KE
    Expert Rev Neurother; 2019 Apr; 19(4):293-299. PubMed ID: 30892103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct relief of levodopa-induced dyskinesia by stimulation in the area above the subthalamic nucleus in a patient with Parkinson's disease--case report.
    Nishikawa Y; Kobayashi K; Oshima H; Fukaya C; Yamamoto T; Katayama Y; Ogawa A; Ogasawara K
    Neurol Med Chir (Tokyo); 2010; 50(3):257-9. PubMed ID: 20339282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of extended-release amantadine in levodopa-induced dyskinesias: a meta-analysis.
    Pajo AT; Espiritu AI; Jamora RDG
    Neurodegener Dis Manag; 2019 Aug; 9(4):205-215. PubMed ID: 31392922
    [No Abstract]   [Full Text] [Related]  

  • 13. Extended-release amantadine (Gocovri) for dyskinesia in Parkinson's disease.
    Med Lett Drugs Ther; 2017 Dec; 59(1535):198-200. PubMed ID: 29186084
    [No Abstract]   [Full Text] [Related]  

  • 14. Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study).
    Pahwa R; Tanner CM; Hauser RA; Sethi K; Isaacson S; Truong D; Struck L; Ruby AE; McClure NL; Went GT; Stempien MJ
    Mov Disord; 2015 May; 30(6):788-95. PubMed ID: 25650051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct effect of subthalamic nucleus stimulation on levodopa-induced peak-dose dyskinesia in patients with Parkinson's disease.
    Katayama Y; Oshima H; Kano T; Kobayashi K; Fukaya C; Yamamoto T
    Stereotact Funct Neurosurg; 2006; 84(4):176-9. PubMed ID: 16905880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amantadine Extended-Release (GOCOVRI
    Paik J; Keam SJ
    CNS Drugs; 2018 Aug; 32(8):797-806. PubMed ID: 30088203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial.
    Pahwa R; Tanner CM; Hauser RA; Isaacson SH; Nausieda PA; Truong DD; Agarwal P; Hull KL; Lyons KE; Johnson R; Stempien MJ
    JAMA Neurol; 2017 Aug; 74(8):941-949. PubMed ID: 28604926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment.
    Thanvi B; Lo N; Robinson T
    Postgrad Med J; 2007 Jun; 83(980):384-8. PubMed ID: 17551069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of amantadine on levodopa-induced dyskinesias in Parkinson's disease: a double-blind, placebo-controlled study.
    Snow BJ; Macdonald L; Mcauley D; Wallis W
    Clin Neuropharmacol; 2000; 23(2):82-5. PubMed ID: 10803797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update.
    AlShimemeri S; Fox SH; Visanji NP
    Expert Opin Emerg Drugs; 2020 Jun; 25(2):131-144. PubMed ID: 32366130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.